Your AI-Trained Oncology Knowledge Connection!
News
Video
Stay up to date on the most recent and practice-changing oncology data
Enfortumab Vedotin Shows Manageable Safety in Older Patients With Urothelial Carcinoma
Neoadjuvant MVAC/Pembrolizumab Generates Unprecedented pCR Rates in Non-Urothelial MIBC: With Chandler Park, MD; Petros Grivas, MD, PhD; and Ruben Raychaudhuri, MD
Fruquintinib/Sintilimab Generates Favorable PFS Outcomes in Advanced RCC
Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD
Casdatifan Monotherapy Shows Early Efficacy Signals and Tolerable Safety Profile in Pretreated ccRCC
MT-8421 Displays Acceptable Safety Profile in First-in-Human Trial for Advanced Solid Tumors
Reduced Radiotherapy Margins Yield Outcomes Comparable With Standard Margins in HGG
Eribulin and Trabectedin Yield Comparable Real-World OS Outcomes in Advanced Liposarcoma
Physical Functioning Measures May Predict Survival Outcomes, ICANS Risk With CAR T-Cell Therapy in NHL
First-Line Atezolizumab Is Suitable in Platinum-Based Chemotherapy Ineligible mUC
%20(1).jpg?fit=crop&auto=format)
